Ultra-Short Antimicrobial Peptoids Show Propensity for Membrane Activity Against Multi-Drug Resistant Mycobacterium tuberculosis
Tuberculosis (TB) results in both morbidity and mortality on a global scale. With drug resistance on the increase, there is an urgent need to develop novel anti-mycobacterials. Thus, we assessed the anti-mycobacterial potency of three novel synthetic peptoids against drug-susceptible and multi-drug...
Main Authors: | Jasmeet Singh Khara, Biljana Mojsoska, Devika Mukherjee, Paul R. Langford, Brian D. Robertson, Håvard Jenssen, Pui Lai Rachel Ee, Sandra M. Newton |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2020.00417/full |
Similar Items
-
Novel tetrameric cell penetrating antimicrobial peptoids effective against mycobacteria and drug-resistant Staphylococcus aureus
by: Bettina Simone Fleck, et al.
Published: (2022-02-01) -
Galleria mellonella: An Infection Model for Screening Compounds Against the Mycobacterium tuberculosis Complex
by: Masanori Asai, et al.
Published: (2019-11-01) -
Nano-topography and functionalization with the synthetic peptoid GN2-Npm9 as a strategy for antibacterial and biocompatible titanium implants
by: Francesca Gamna, et al.
Published: (2024-01-01) -
Dual delivery of antigens shows promise
by: Jose L Luque-García, et al.
Published: (2023-07-01) -
Membrane‐acting biomimetic peptoids against visceral leishmaniasis
by: Vivek Kumar, et al.
Published: (2023-03-01)